Advanced prostate cancer with ATM loss: PARP and ATR inhibitors
European Urology, November 2020
Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer
Journal of Urology, November 2020
Selecting patients with favourable-risk, GG2 prostate cancer for active surveillance: Does MRI have a role?
Journal of Urology, November 2020
The use of healthcare services by prostate cancer patients in the last 12 months of life: How do we improve the quality of care during this period?
Journal of Palliative Care, November 2020
A DROP-IN gamma probe for robot-assisted radioguided surgery of lymph nodes during radical prostatectomy
European Urology, November 2020
Risk of cardiovascular disease following gonadotropinâreleasing hormone agonists vs antagonists in prostate cancer: Realâworld evidence from five databases
International Journal of Cancer, November 2020
The long-term risks of metastases in men on active surveillance for early stage prostate cancer
The Journal of Urology, December 2020
Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging
The journal of Nuclear Medicine, November 2020
Association between African American race and clinical outcomes in men treated for low-risk prostate cancer with active surveillance
JAMA., November 2020
Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection
Are confirmatory biopsies needed in patients on active surveillance who underwent upfront MRI with possible targeted biopsy?
Racial/ethnic variation in PSA testing and prostate cancer incidence following the 2012 U.S.P.S.T.F. recommendation
Journal of the National Cancer Institute, November 2020
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More